ELAB vs MS · rev $1.7M vs P/E 20, $344.27B cap
Elevai Labs, Inc. Common Stock (ELAB) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported ELAB revenue for 2023-12-31 was $1.7M. Net income was -$4.3M. Revenue was up 123.5% from 2022-12-31 to 2023-12-31. ELAB currently screens at market cap $6.5M.
MS does not have a complete income-statement cache yet.
ELAB currently screens at market cap $6.5M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the ELAB and MS stock pages for the full models.
Not investment advice.